Foster & Motley Inc. Sells 3,927 Shares of Aflac Incorporated (NYSE:AFL)

Foster & Motley Inc. decreased its holdings in shares of Aflac Incorporated (NYSE:AFL) by 3.6% during the third quarter, HoldingsChannel reports. The fund owned 104,945 shares of the financial services provider’s stock after selling 3,927 shares during the quarter. Foster & Motley Inc.’s holdings in Aflac were worth $11,733,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently made changes to their positions in AFL. Y.D. More Investments Ltd purchased a new stake in shares of Aflac in the 2nd quarter valued at about $25,000. Catalyst Capital Advisors LLC purchased a new stake in Aflac in the third quarter valued at approximately $51,000. Valued Wealth Advisors LLC lifted its position in Aflac by 116.7% during the third quarter. Valued Wealth Advisors LLC now owns 479 shares of the financial services provider’s stock valued at $54,000 after purchasing an additional 258 shares during the last quarter. Fairscale Capital LLC purchased a new position in Aflac in the 2nd quarter worth approximately $54,000. Finally, Cedar Wealth Management LLC bought a new position in shares of Aflac in the 1st quarter worth $50,000. 67.44% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have issued reports on AFL shares. Wells Fargo & Company lifted their price target on Aflac from $106.00 to $107.00 and gave the stock an “equal weight” rating in a research note on Tuesday. UBS Group raised their target price on Aflac from $84.00 to $109.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 14th. Citigroup upped their price target on Aflac from $84.00 to $93.00 and gave the company a “neutral” rating in a research report on Tuesday, July 23rd. TD Cowen initiated coverage on Aflac in a research report on Wednesday, October 9th. They issued a “hold” rating and a $102.00 price objective on the stock. Finally, Barclays began coverage on Aflac in a report on Wednesday, September 4th. They set an “underweight” rating and a $96.00 target price for the company. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $97.93.

Aflac Price Performance

Shares of NYSE AFL opened at $105.52 on Wednesday. The company has a 50 day moving average of $110.42 and a 200 day moving average of $98.25. The company has a quick ratio of 0.10, a current ratio of 0.08 and a debt-to-equity ratio of 0.32. Aflac Incorporated has a twelve month low of $75.07 and a twelve month high of $115.50. The firm has a market cap of $59.09 billion, a P/E ratio of 15.89, a PEG ratio of 2.07 and a beta of 0.96.

Aflac (NYSE:AFL) last announced its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $2.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.69 by $0.47. The firm had revenue of $2.95 billion for the quarter, compared to the consensus estimate of $4.30 billion. Aflac had a return on equity of 16.34% and a net margin of 22.02%. The company’s quarterly revenue was down 40.4% on a year-over-year basis. During the same period in the prior year, the company posted $1.84 earnings per share. As a group, research analysts expect that Aflac Incorporated will post 7.05 EPS for the current fiscal year.

Aflac Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, December 2nd. Shareholders of record on Wednesday, November 20th will be paid a dividend of $0.50 per share. The ex-dividend date is Wednesday, November 20th. This represents a $2.00 dividend on an annualized basis and a yield of 1.90%. Aflac’s dividend payout ratio is presently 30.12%.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.